Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes Mellitus
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT03102424
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 160 participants
- Sponsor
- Taiwan Resonant Waves Research Corporation
- Registry
-
NCT03102424
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT03102424. Randomized; quadruple masking; primary purpose supportive care. Start 2017-04-10 (actual); primary completion 2020-07-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Device)
- Transcutaneous Electrical Nerve Stimulator (DW1330)
- Intervention (Device)
- Sham DW1330 device
- Lead sponsor
- Taiwan Resonant Waves Research Corporation
Record details
- Record id
cardio:ct-nct03102424- Content hash
a0d1b1e08599ddbea4aaf97d4880a3d3d14e5f08fda9ca62561891065a3b7e2e